TR200201211T2 - Pulmoner hastalıkların tedavisi için metod ve terkipler. - Google Patents

Pulmoner hastalıkların tedavisi için metod ve terkipler.

Info

Publication number
TR200201211T2
TR200201211T2 TR2002/01211T TR200201211T TR200201211T2 TR 200201211 T2 TR200201211 T2 TR 200201211T2 TR 2002/01211 T TR2002/01211 T TR 2002/01211T TR 200201211 T TR200201211 T TR 200201211T TR 200201211 T2 TR200201211 T2 TR 200201211T2
Authority
TR
Turkey
Prior art keywords
treatment
compositions
methods
pulmonary diseases
diseases
Prior art date
Application number
TR2002/01211T
Other languages
English (en)
Turkish (tr)
Inventor
N. Goodfellow Peter
Nieman Richard
J. Torphy Theodore
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of TR200201211T2 publication Critical patent/TR200201211T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TR2002/01211T 1999-11-02 2000-11-01 Pulmoner hastalıkların tedavisi için metod ve terkipler. TR200201211T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16315899P 1999-11-02 1999-11-02

Publications (1)

Publication Number Publication Date
TR200201211T2 true TR200201211T2 (tr) 2002-08-21

Family

ID=22588737

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2002/01211T TR200201211T2 (tr) 1999-11-02 2000-11-01 Pulmoner hastalıkların tedavisi için metod ve terkipler.

Country Status (29)

Country Link
EP (1) EP1225866A4 (es)
JP (1) JP2003513028A (es)
KR (1) KR20020057988A (es)
CN (1) CN1387404A (es)
AP (1) AP2002002496A0 (es)
AR (1) AR029189A1 (es)
AU (1) AU1357501A (es)
BG (1) BG106748A (es)
BR (1) BR0015270A (es)
CA (1) CA2388333A1 (es)
CO (1) CO5261512A1 (es)
CZ (1) CZ20021512A3 (es)
DZ (1) DZ3225A1 (es)
EA (1) EA200200518A1 (es)
EC (1) ECSP003747A (es)
HK (1) HK1049107A1 (es)
HU (1) HUP0203152A3 (es)
IL (1) IL149367A0 (es)
MA (1) MA26841A1 (es)
MX (1) MXPA02004350A (es)
NO (1) NO20022057L (es)
OA (1) OA12076A (es)
PE (1) PE20011005A1 (es)
PL (1) PL355261A1 (es)
SK (1) SK7592002A3 (es)
TR (1) TR200201211T2 (es)
TW (1) TWI242431B (es)
WO (1) WO2001032127A2 (es)
ZA (1) ZA200203435B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100496607C (zh) * 2001-09-19 2009-06-10 尼科梅德有限责任公司 Nsaid与pde-4抑制剂的并用药物
CA2462525A1 (en) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Type 4 phosphodiesterase inhibitors and uses thereof
UA82323C2 (uk) * 2002-08-09 2008-04-10 Меда Фарма Гмбх & Ко. Кг Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань
TW200410923A (en) * 2002-10-17 2004-07-01 Ono Pharmaceutical Co Therapeutic agent for chronic obstructive pulmonary disease
EP1616569A1 (en) * 2003-03-31 2006-01-18 Kyowa Hakko Kogyo Co., Ltd. Medicinal composition
US20050026883A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease
CA2584169A1 (en) * 2004-10-13 2006-04-20 Kyowa Hakko Kogyo Co., Ltd. Remedies/preventives for chronic skin disease
AU2006305620A1 (en) * 2005-10-19 2007-04-26 Ranbaxy Laboratories Limited Compositions of phosphodiesterase type IV inhibitors
ES2702753T3 (es) 2010-01-05 2019-03-05 Microdose Therapeutx Inc Dispositivo de inhalación
WO2015063669A1 (en) 2013-10-30 2015-05-07 Wockhardt Limited Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT710109E (pt) * 1993-06-18 2005-01-31 Smithkline Beecham Corp Metodo para identificar um inibidor de pde iv
DE4332041C2 (de) * 1993-09-21 1997-12-11 Rentschler Arzneimittel Verwendung von Pentoxifyllin bei bestimmten Lungenerkrankungen
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias
SE9801368D0 (sv) * 1998-04-20 1998-04-20 Astra Ab New use

Also Published As

Publication number Publication date
PE20011005A1 (es) 2001-09-28
CZ20021512A3 (cs) 2003-04-16
ZA200203435B (en) 2003-06-25
MA26841A1 (fr) 2004-12-20
DZ3225A1 (fr) 2001-05-10
CA2388333A1 (en) 2001-05-10
EP1225866A2 (en) 2002-07-31
KR20020057988A (ko) 2002-07-12
AP2002002496A0 (en) 2002-06-30
NO20022057D0 (no) 2002-04-30
EA200200518A1 (ru) 2002-10-31
OA12076A (en) 2006-05-04
JP2003513028A (ja) 2003-04-08
AU1357501A (en) 2001-05-14
HK1049107A1 (zh) 2003-05-02
PL355261A1 (en) 2004-04-05
WO2001032127A3 (en) 2001-12-06
MXPA02004350A (es) 2002-11-07
TWI242431B (en) 2005-11-01
CO5261512A1 (es) 2003-03-31
AR029189A1 (es) 2003-06-18
HUP0203152A3 (en) 2004-06-28
ECSP003747A (es) 2002-05-23
CN1387404A (zh) 2002-12-25
HUP0203152A2 (hu) 2003-01-28
NO20022057L (no) 2002-06-27
WO2001032127A2 (en) 2001-05-10
BG106748A (en) 2003-02-28
BR0015270A (pt) 2002-06-18
IL149367A0 (en) 2002-11-10
EP1225866A4 (en) 2004-04-21
SK7592002A3 (en) 2002-11-06

Similar Documents

Publication Publication Date Title
TR200100500T2 (tr) Pulmoner hastalıkların tedavisi için terapiler
UY28958A1 (es) Nuevos derivados de piridazin-3(2h)-ona
ATE486840T1 (de) Modifizierte formen pharmazeutisch aktiver agenzien und verwendungen dafür
BR0210904A (pt) Uso de inibidores de il-18 para o tratamento ou prevenção de sepse
BRPI0411825A (pt) inibidores de p38 quinase a base de heterociclo de 5 elementos
TR200102110T2 (tr) Astım için formoterol ve flütikazon propiyonat kombinasyonları.
BRPI0407922A (pt) derivados de isoquinolina e métodos de uso destes
WO2001083554A3 (en) Anti-inflammatory compounds and uses thereof
CY1108274T1 (el) Μακροβιο ομοιαζον με γλυκογονο πεπτιδιο 2 (glp-2) για την θεραπεια γαστρεντερικων ασθενειων και διαταραχων
BR0317572A (pt) Benzoxazinas e seus derivados como inibidores de pi3ks
AP2001002217A0 (en) Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids.
EA200300293A1 (ru) Противовоспалительные конденсированные пирролокарбазолы
ATE497770T1 (de) Pharmazeutische formulierungen von decitabin
CY1105225T1 (el) Παραγωγα 5-β-σαπωγενινης και ψευδοσαπωγενινης και η χρηση τους στην αντιμετωπιση ανοιας
WO2000045800A3 (en) Immunosurpressive effects of pteridine derivatives
TR200201211T2 (tr) Pulmoner hastalıkların tedavisi için metod ve terkipler.
CR6824A (es) Derivados de arilmetilamina para uso como inhibidores de triptasa
MXPA03008423A (es) Agonistas del receptor nicotinico para el tratamiento de enfermedades inflamatorias.
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
AP2003002753A0 (en) Use of salmeterol and fluticasone propionate combination
PT1268472E (pt) Inibidores 3-aminopirazolicos de cinases dependentes da ciclina
BR9910696A (pt) Composições farmacêuticas
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
BRPI0416202A (pt) formulações inibidoras de fosfodiesterase v